Liz Parrish shows gene therapies to be a successful formula to increase longevity
Considered to be the “patient zero” of this type of treatment, Parrish shares her experimental case at the second edition of the Longevity World Forum. Telomerase, follistatin and klotho are the elements on which she is currently working at her biotechnology firm to combat aging.
Liz Parrish visits Spain to talk about her experience as “patient zero” of the first successful gene therapy against aging
The founder and CEO of BioViva Science, one of the ten most innovative companies in the world in its sector, will participate at the Longevity World Forum. Liz Parrish will also explain the latest breakthroughs being achieved by her company with a view to developing a “rejuvenating vaccine”.